May
30th
6:00 PM – 7:00 PM ET
Virtual Event
This webinar will feature: Highlight the neurodevelopmental and quality of life outcomes in patients with symptomatic tetralogy of Fallot, with a focus on the role of primary treatment pathway and evaluate variation in cumulative radiation exposure and lifetime attributable cancer risk in management of infants with symptomatic tetralogy of Fallot.